Institutional investors purchased a net $1.4 million shares of RGEN during the quarter ended June 2014, and now own 89.66% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 976.3 Thousand shares of Repligen Corp
CONESTOGA CAPITAL ADVISORS LLC Bought 821.4 Thousand shares of Repligen Corp
FEDERATED GLOBAL INVESTMENT MANA... Bought 524.3 Thousand shares of Repligen Corp